MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, P.
Right arrow Articles by Wahli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, P.
Right arrow Articles by Wahli, W.

Vol. 56, Issue 3, 526-536, September 1999

Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor 11

Pascal Bernard, Hervé Goudonnet, Yves Artur, Béatrice Desvergne, and Walter Wahli

Institut de Biologie Animale, Bâtiment de Biologie, Université de Lausanne, Lausanne, Switzerland (P.B., B.D., W.W.); and Laboratoire de Biochimie Pharmacologique, Unité de Formation et de Recherche Pharmacie, Université de Bourgogne, Dijon, France (P.B., H.G., Y.A.)

UDP-glucuronosyltransferase (UGT) 1A1 (UGT1A1) catalyzes the glucuronidation of bilirubin in liver. Among all UGT isoforms identified to date, it is the only relevant bilirubin-glucuronidating enzyme in human. Because glucuronoconjugation is the major route of bilirubin elimination, any genetic alteration that affects bilirubin glucuronosyltransferase activity may result in a more or less severe hyperbilirubinemia. In this study, we report the cloning and characterization of the transcriptional regulation of the mouse UGT1A1 gene. Primary-structure analysis of the mouse Thymidine Adevice promoter revealed marked differences with its human homolog. First, the mouse promoter lacks the highly polymorphic thymidine/adenine repeat occurring in the human promoter, which has been associated with some forms of hyperbilirubinemia. Second, an L1 transposon element, which is absent in the human promoter, is found 480 bp upstream of the transcription start site in mouse. Using the electromobility shift and DNase I footprinting experiments, we have identified a hepatocyte nuclear factor 1-binding site in the mouse UGT1A1 promoter that confers responsiveness to both factors HNF1alpha and HNF1beta in HEK293 cells. Furthermore, we show that this element, which is conserved in the human promoter, also confers strong HNF1 responsiveness to the human UGT1A1 gene. Together, these results provide evidence for a major regulatory function of this liver-enriched transcription factor in UGT1A1 activity in both rodents and human.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
D. A. Gardner-Stephen and P. I. Mackenzie
Isolation of the UDP-Glucuronosyltransferase 1A3 and 1A4 Proximal Promoters and Characterization of Their Dependence on the Transcription Factor Hepatocyte Nuclear Factor 1{alpha}
Drug Metab. Dispos., January 1, 2007; 35(1): 116 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-F. Gagnon, O. Bernard, L. Villeneuve, B. Tetu, and C. Guillemette
Irinotecan Inactivation Is Modulated by Epigenetic Silencing of UGT1A1 in Colon Cancer
Clin. Cancer Res., March 15, 2006; 12(6): 1850 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Pramfalk, M. A. Davis, M. Eriksson, L. L. Rudel, and P. Parini
Control of ACAT2 liver expression by HNF1
J. Lipid Res., September 1, 2005; 46(9): 1868 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Carcinogenesis, September 1, 2004; 25(9): 1629 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. A. Gregory, R. H. Lewinsky, D. A. Gardner-Stephen, and P. I. Mackenzie
Coordinate Regulation of the Human UDP-Glucuronosyltransferase 1A8, 1A9, and 1A10 Genes by Hepatocyte Nuclear Factor 1{alpha} and the Caudal-Related Homeodomain Protein 2
Mol. Pharmacol., April 1, 2004; 65(4): 953 - 963.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
P. G. Wells, P. I. Mackenzie, J. Roy Chowdhury, C. Guillemette, P. A. Gregory, Y. Ishii, A. J. Hansen, F. K. Kessler, P. M. Kim, N. Roy Chowdhury, et al.
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
Drug Metab. Dispos., March 1, 2004; 32(3): 281 - 290.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Gregory, D. A. Gardner-Stephen, R. H. Lewinsky, K. N. Duncliffe, and P. I. Mackenzie
Cloning and Characterization of the Human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 Gene Promoters: DIFFERENTIAL REGULATION THROUGH AN INITIATOR-LIKE REGION
J. Biol. Chem., September 19, 2003; 278(38): 36107 - 36114.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Y. Kato, K. Haraguchi, T. Yamazaki, Y. Ito, S. Miyajima, K. Nemoto, N. Koga, R. Kimura, and M. Degawa
Effects of Polychlorinated Biphenyls, Kanechlor-500, on Serum Thyroid Hormone Levels in Rats and Mice
Toxicol. Sci., April 1, 2003; 72(2): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. A. Gregory and P. I. Mackenzie
The Homeodomain Pbx2-Prep1 Complex Modulates Hepatocyte Nuclear Factor 1alpha -Mediated Activation of the UDP-Glucuronosyltransferase 2B17 Gene
Mol. Pharmacol., July 1, 2002; 62(1): 154 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Toide, Y. Takahashi, H. Yamazaki, Y. Terauchi, T. Fujii, A. Parkinson, and T. Kamataki
Hepatocyte Nuclear Factor-1alpha Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
Drug Metab. Dispos., June 1, 2002; 30(6): 613 - 615.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. G. McCarver and R. N. Hines
The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 361 - 366.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine, et al.
Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
Drug Metab. Dispos., April 13, 2001; 29(5): 623 - 633.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
R. P. Metz, D. J. Auyeung, F. K. Kessler, and J. K. Ritter
Involvement of Hepatocyte Nuclear Factor 1 in the Regulation of the UDP-Glucuronosyltransferase 1A7 (UGT1A7) Gene in Rat Hepatocytes
Mol. Pharmacol., August 1, 2000; 58(2): 319 - 327.
[Abstract] [Full Text]

Home page
 Genome ResHome page
W. Krivan and W. W. Wasserman
A Predictive Model for Regulatory Sequences Directing Liver-Specific Transcription
Genome Res., September 1, 2001; 11(9): 1559 - 1566.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics